A two-year comparative study on varicella-zoster virus incidence before and after COVID-19

Basit Öğe Kaydı
dc.authorid0000-0002-3916-4964
dc.authorid0000-0003-2881-6522
dc.authorid0000-0002-0774-2766
dc.contributor.authorHeydari, Daryuş
dc.contributor.authorKaya, Çağdaş
dc.contributor.authorHeydari, Ayli
dc.contributor.authorSezgin, Gülbüz
dc.date.accessioned2024-10-08T07:36:44Z
dc.date.available2024-10-08T07:36:44Z
dc.date.issued2024
dc.departmentFakülteler, Tıp Fakültesi
dc.description.abstractObjective: This study aimed to assess and compare the prevalence and characteristics of herpes zoster cases before and after the COVID-19 pandemic, focusing on the potential impact of SARS-CoV-2 infection and COVID-19 vaccination. Methods: A retrospective analysis was conducted on herpes zoster cases diagnosed in 2019 and 2022. Data collected included patient demographics, lesion distributions, COVID-19 PCR test results, and vaccination statuses. Statistical analyses using SPSS were performed to compare findings between the two periods. Results: In 2019, 25 out of 1578 patients (1.584%) were diagnosed with herpes zoster, whereas in 2022, the number rose to 40 out of 3024 patients (1.322%), reflecting a 60% increase in case numbers but a 0.262% decrease in incidence rate. The average patient age decreased from 62 years in 2019 to 58.6 years in 2022. Among the 2022 cases, 35% tested positive for COVID-19, and vaccination statuses varied, with 27.5% having received four vaccine doses. Conclusion: The study indicates a significant rise in herpes zoster cases post-COVID-19 pandemic and vaccination era, despite a decrease in incidence rates. This surge may be linked to direct and indirect effects of SARS-CoV-2 infection, vaccine-induced immune responses, and pandemic-related stress. Further investigation is warranted to delve into underlying mechanisms and potential causal relationships in greater depth.
dc.identifier.citationHeydari D., Kaya C., Heydari A. ve Sezgin G. (2024). A two-year comparative study on varicella-zoster virus incidence before and after COVID-19. Open Journal of Clinical & Medical Case Reports, (10), s.1-7.
dc.identifier.endpage7
dc.identifier.issn2379-1039
dc.identifier.issue10
dc.identifier.startpage1
dc.identifier.urihttps://hdl.handle.net/20.500.12415/12873
dc.language.isoen
dc.publisherOpen Journal of Clinical & Medical Case Reports
dc.relation.ispartofOpen Journal of Clinical & Medical Case Reports
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectVaricella-Zoster Virus (VZV) reactivation
dc.subjectCausing herpes zoster infections
dc.subjectStress associated with the pandemic
dc.subjectVaccination efforts
dc.titleA two-year comparative study on varicella-zoster virus incidence before and after COVID-19
dc.typeArticle
dspace.entity.typePublication

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim
İsim:
Daryuş Heydari ve diğerleri, A two-year comparative study on varicella-zoster virus
Boyut:
1 MB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin / Full Text
İndir
Lisans paketi
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
license.txt
Boyut:
1.17 KB
Biçim:
Item-specific license agreed to upon submission
Açıklama:
İndir

Koleksiyon

Tıp Fakültesi Koleksiyonu